Resonance Specialities Q4 FY26 Results: PAT of Rs 4.59 crore Specialty Chemicals – Aroma Chemicals

May 15, 2026
Posted by: Kunal Singla
Category: News

Resonance Specialities Q4 FY26 results were announced on May 14, 2026, at the company’s board meeting. the company net profit increased to Rs 4.59 crore. The company manufactures aroma chemicals and specialty materials for fragrance, flavour, and personal care applications. Investors tracking the company will find complete financial data, analysis, and FY27 outlook in this article.

Click Here – Get Free Investment Predictions

Table of Contents

Resonance Specialities Q4 FY26 Key Financial Highlights

Metric	Q4 FY26	Comparison
PAT (Net Profit)	Rs 4.59 crore	Q4 FY25 / Reference
Ticker	RESONANCE	Sector: Specialty Chemicals – Aroma Chemicals

Screen the best stocks on the Univest Screener.

Resonance Specialities Performance Analysis

The company results reflect the company’s operational performance during the January to March 2026 quarter. the company net profit increased to Rs 4.59 crore. The company manufactures aroma chemicals and specialty materials for fragrance, flavour, and personal care applications. Investors and analysts monitoring the company results will focus on FY27 revenue guidance, margin trajectory, and management commentary on business outlook.

The company performance positions the company for FY27. Track the company analyst ratings and live stock price on the Univest Screener for real-time investment insights.

Resonance Specialities FY27 Outlook

Post Resonance, investor focus for FY27 will be on revenue growth momentum, margin expansion, new order wins, and sector-specific tailwinds in the Specialty Chemicals – Aroma Chemicals space. The Resonance results demonstrate the company’s execution capabilities. Track Resonance updates on the Univest Screener for analyst views and FY27 earnings estimates.

Download the Univest iOS App or the Univest Android App to track live price and Q4 FY26 earnings updates.

Frequently Asked Questions on Resonance Specialities Q4 FY26 Results

What is it PAT?

Ans. Resonance profit after tax was Rs 4.59 crore.

When did Resonance Specialities announce Q4 FY26 results?

Ans. the company results were announced on May 14, 2026, at the company’s board meeting and filed with BSE and NSE.

What is the FY27 outlook for Resonance Specialities?

Ans. Post the company results, investors will track FY27 guidance and growth strategies in the Specialty Chemicals – Aroma Chemicals sector. Track live updates on the Univest Screener.

Where can I track the company live data?

Ans. Track the company live stock price, analyst ratings, and earnings updates on the Univest Screener for real-time investment data.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered advisor before making any investment decision.

Author: Kunal Singla

Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.